# Chromium Piccolinate in the Prevention of Weight Gain Induced by Serotonergic Medications Initiated on Psychiatric Inpatient Units.

> **NCT00759993** · PHASE2 · TERMINATED · sponsor: **State University of New York - Upstate Medical University** · enrollment: 60 (estimated)

## Conditions studied

- Weight Gain
- Obesity

## Interventions

- **DRUG:** chromium piccolinate
- **DRUG:** placebo for chromium piccolinate

## Key facts

- **NCT ID:** NCT00759993
- **Lead sponsor:** State University of New York - Upstate Medical University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2008-09
- **Primary completion:** 2012-06
- **Final completion:** 2013-03
- **Target enrollment:** 60 (ESTIMATED)
- **Why stopped:** inability to recruit and retain
- **Last updated:** 2012-09-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00759993

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00759993, "Chromium Piccolinate in the Prevention of Weight Gain Induced by Serotonergic Medications Initiated on Psychiatric Inpatient Units.". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00759993. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*